News and Updates by the Food and Drugs Administration (FDA)
India is observing an unexpected surge in lung cancer cases among individuals who have never smoked, challenging traditional views and causing concern within the medical field. Dr. Aravind Badiger, the technical director of BDR Pharmaceuticals, highlights this trend as a […]
Today, a Texas hospital revealed its team of electrophysiologists successfully completed the inaugural procedures in the United States using the Affera platform by Medtronic (NYSE:MDT). Staff at the Texas Cardiac Arrhythmia Institute (TCAI) located at St. David’s Medical Center utilized
First U.S. Procedures Use Medtronic Affera Ablation Platform Read More »
Zimmer Biomet (NYSE:ZBH) today announced it has obtained 510(k) clearance from the FDA for its Persona SoluTion porous plasma spray femur. This innovative knee implant component provides a beneficial option for individuals who are sensitive to traditional bone cement and/or
Zimmer Biomet Secures FDA Approval for New Knee Implant Component Read More »
The Consortium of the All India Pharmaceutical Association (AIPAC), in collaboration with the Society for Pharmaceutical Dissolution Science (SPDS) and the Indian Pharmaceutical Manufacturers Association’s Madhya Pradesh division (MP IDMA), will be hosting a one-day symposium focused on ‘Dissolution Science
The Karnataka government has named BP Arun, the Deputy Drug Controller at the Mysuru regional office, as the latest authority for licensing, controlling, and approving in the state’s drug control department. Arun steps in as the successor to Dr. Umesh
BP Arun Takes Charge as Karnataka’s New Drug Control Licensing Authority Read More »
MediBuddy has unveiled the India Health Care Collaborators (IHCC), a platform designed to bring together insurance companies, brokers, and healthcare providers. This initiative is focused on enhancing access to a secure, cashless primary healthcare system. The new platform, called BuddyCare,
MediBuddy Introduces IHCC, a Network for Seamless Insurance-Linked Healthcare Services Read More »
**Swedish Innovator Nyctea Technologies Seeks Growth in Drug Purification Technologies** Nyctea Technologies, a Swedish startup focused on both deeptech and medtech, is setting its sights on expanding into new markets with its pioneering biomolecular purification system. Originating as a project
Revolutionizing Drug Development: Nyctea Technologies Introduces Electro-Purification Read More »
Medexus Pharmaceuticals, recognized as a prominent specialty pharmaceutical company with a robust North American presence and an expanding range of unique treatments for rare disorders, recently declared that it has reached a fourth amendment to its exclusive licensing agreement from
Eppendorf SE, a renowned leader in the life sciences sector, has joined forces with DataHow AG, an innovator in advanced data analytics and AI-driven prediction software, to announce a strategic collaboration aimed at revolutionizing bioprocess development. This partnership will allow
Eppendorf and DataHow Unite to Enhance Bioprocess Data Management Read More »
Senti Biosciences, Inc., a biotechnology firm currently in the clinical-stage, is advancing innovative cell and gene therapies via its unique gene circuit platform. The company has finalized a securities purchase agreement, permitting select existing and new accredited investors to purchase